The announcement of interim data from a significant study can often influence a biotech company's stock price, as it provides insight into the potential success of the company's ongoing research. The investor event also provides an opportunity for the company to influence investor sentiment. However, without specific details on the data, it's difficult to predict the direction of the impact.